Reuters: Money News: U.S. approves Mylan's purchase of Bangalore-based Agila, with conditions
Reuters: Money News
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
WASHINGTON (Reuters) - Generic drugmaker Mylan Inc has won U.S. antitrust approval to buy Agila, a unit of India's Strides Arcolab Ltd , subject to divesting some products, the Federal Trade Commission said on Thursday.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment